NanJing Pharmaceutical Co Ltd
SSE:600713
NanJing Pharmaceutical Co Ltd
Income to Minority Interest
NanJing Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Income to Minority Interest
-¥138.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-20%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Income to Minority Interest
-¥6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-16%
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Income to Minority Interest
-¥1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-13%
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Income to Minority Interest
-¥82.8m
|
CAGR 3-Years
35%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Income to Minority Interest
-¥188.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-30%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Income to Minority Interest
-¥729.9k
|
CAGR 3-Years
81%
|
CAGR 5-Years
64%
|
CAGR 10-Years
42%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
-138.4m
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Income to Minority Interest amounts to -138.4m CNY.
What is NanJing Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
-20%
Over the last year, the Income to Minority Interest growth was -2%. The average annual Income to Minority Interest growth rates for NanJing Pharmaceutical Co Ltd have been -13% over the past three years , -7% over the past five years , and -20% over the past ten years .